혈관성치매에 대한 한·양방 치료약물의 처방 사례연구
A Case Study on Drug Prescription for Vascular Dementia in Western and Oriental Medicine
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives : Vascular dementia is the second common cause of dementia after Alzheimer’s disease. It assumed that the ratio of prescription drugs on vascular dementia are quite different from each hospital in Western medicine or Oriental medicine, respectively. The aim of this research is to collect and analyze the ratio of prescription drugs on vascular dementia in Western medicine or Oriental medicine in university hospitals. Methods : We collected and analyzed the data related to prescriptions on vascular dementia in the department of neurology in three university hospitals(A, B, C) and in the department of internal medicine in two Oriental medicine hospitals(Daegu Haany Oriental Hospital, Dong Eui Oriental Hospital). Results : In the department of neurology in A university hospital, donepezil(69.1%), memantine(14.0%),rivastigmine(12.3%), galantamine(4.5%) were prescribed in order. In B university hospital, galantamine (57.8%) donepezil(33.3%), rivastigmine(6.7%), donepezil with memantine(4.4%) were prescribed. In C university hospital, donepezil(62.0%), rivastigmine(25.0%), galantamine(7.0%) memantine(6.0%) were prescribed. The average frequencies of prescribed medication in the department of neurology in A, B, C university hospitals were donepezil(54.8%), galantamine(23.1%), rivastigmine(14.7%), memantine(7.4%). In Oriental medicine hospitals, various prescriptions have been used for vascular dementia. Among them, Ansincheongnoetang (安神淸腦湯) and Gamijihangeumja(加味地黃飮子) were often prescribed in Daegu Haany Oriental Hospital,and Bojungikgitang(補中益氣湯) in Dong Eui Oriental Hospital, too. Conclusions : Cholinesterase inhibitors such as donepezil, galantamine, rivastigmine and NMDA receptor inhibitor like memantine have been used as a drug of choice for vascular dementia in all surveyed university hospitals. In oriental hospitals, various prescriptions have been used for vascular dementia.
Abstract
Objectives : Vascular dementia is the second common cause of dementia after Alzheimer’s disease. It assumed that the ratio of prescription drugs on vascular dementia are quite different from each hospital in Western medicine or Oriental medicine, respectively. The aim of this research is to collect and analyze the ratio of prescription drugs on vascular dementia in Western medicine or Oriental medicine in university hospitals. Methods : We collected and analyzed the data related to prescriptions on vascular dementia in the department of neurology in three university hospitals(A, B, C) and in the department of internal medicine in two Oriental medicine hospitals(Daegu Haany Oriental Hospital, Dong Eui Oriental Hospital). Results : In the department of neurology in A university hospital, donepezil(69.1%), memantine(14.0%),rivastigmine(12.3%), galantamine(4.5%) were prescribed in order. In B university hospital, galantamine (57.8%) donepezil(33.3%), rivastigmine(6.7%), donepezil with memantine(4.4%) were prescribed. In C university hospital, donepezil(62.0%), rivastigmine(25.0%), galantamine(7.0%) memantine(6.0%) were prescribed. The average frequencies of prescribed medication in the department of neurology in A, B, C university hospitals were donepezil(54.8%), galantamine(23.1%), rivastigmine(14.7%), memantine(7.4%). In Oriental medicine hospitals, various prescriptions have been used for vascular dementia. Among them, Ansincheongnoetang (安神淸腦湯) and Gamijihangeumja(加味地黃飮子) were often prescribed in Daegu Haany Oriental Hospital,and Bojungikgitang(補中益氣湯) in Dong Eui Oriental Hospital, too. Conclusions : Cholinesterase inhibitors such as donepezil, galantamine, rivastigmine and NMDA receptor inhibitor like memantine have been used as a drug of choice for vascular dementia in all surveyed university hospitals. In oriental hospitals, various prescriptions have been used for vascular dementia.
참고문헌 (19)
- 조맹제, "국내 치매 노인 유병률 현황과 위험 요인", 보건복지포럼, 통권 : 156, pp.43~48 (2009)
- Roman GC, "Vascular dementia : distinguishing characteristics, treatment and prevention", J Am Geriatr Soc, 51, pp.296~304 (2003)
- 구본대, "치매 임상적 접근", pp.413~425 (2006), 아카데미아
- 최성훈, "피질하 혈관성치매의 진단, 치료 및 예방:1례 보고와 함께", 대한예방한의학회지, 14(3), pp.63~75 (2010), 대한예방한의학회
- Rockwood K, "Vascular cognitive impairment and vascular dementia", J Neurol Sci, 203, pp.23~27 (2002)
- Vinters HV, "Neuropathologic substrates of ischemic vascular dementia", J Neuropathol Exp Neurol, 60, pp.658~659 (2000)
- Román GC, "Donepezil in vascular dementia : combined analysis of two large-scale clinical trials", Dement Geriatr Cogn Disord, 20(6), pp.338~344 (2005)
- Black S, "Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia : positive results of a 24-week, multicenter, international, randomized, placebocontrolled clinical trial", Stroke, 34(10), pp.2323~2330 (2003)
- Heinrich M, "Galanthamine from snowdrop-the development of a modern drug against Alzheimer’s disease from local Caucasian knowledge", J Ethnopharmacol, 92(2), pp.147~162 (2004)
- Santos MD, "The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system", Mol Pharmacol, 61, pp.1222~1234 (2002)
- Erkinjuntti T, "Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease : A randomised trial", Lancet, 359, pp.1283~1290 (2002)
- Onor ML, "Rivastigmine in the treatment of Alzheimer’s disease : an update", Clin Interv Aging, 2(1), pp.17~32 (2007)
- Moretti R, "Rivastigmine in subcortical vascular dementia : An open 22-month study", J Neurol Sci, 203, pp.141~146 (2002)
- Lancelot E, "Glutamate toxicity in chronic neurodegenerative disease", Prog Brain Res, 116, pp.331~347 (1998)
- Orgogozo JM, "Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial(MMM 300)", Stroke, 33, pp.1834~1839 (2002)
- "대전대학교 한방병원처방집", pp.118~ (1997), 한국출판사
- 이상룡, "安神淸腦湯이 알츠하이머질환 병태 모델의생화학적 변화 및 기억에 미치는 영향", 동의생리병리학회지, 15(5), pp.708~722 (2001), 대한동의병리학회
- 김상찬, "방제학", pp.462~464 (1999), 영림사
- 최인선, "補中益氣湯 및 그 加味方을 투여한 중풍환자에 대한 임상적 고찰", 대한한방내과학회지, 25(3), pp.388~397 (2004), 대한한방내과학회